Greg B.Scott (middle) attended a panel discussion during the convention. [Photo provided to Newsgd.com]
Greg Scott and his companies’ experience is one of the examples showcasing the development of the bio-industry in Guangdong. The province is focusing on the development of its bio-tech industry, especially during the 13th Five-Year-Plan period.
According to statistics unveiled during the forum, the output of bio-industry in Guangdong exceeded 300 billion yuan in 2016, and is expected to exceed 500 billion yuan by 2020.
Apart from the Zhuhai’s pharmaceutical park, Greg Scott said he is also very familiar with the bio-island in Guangzhou and knew that GE and Beigene were building biologic manufacturing plants here.
“I think the industry is really starting to come up now in Guangdong,” he said.
Talking about the elements to drive overseas biotech enterprises, Scott said it was important for the province to create an eco-system of support which includes investment, policies, business partners, talents and etc.
“Developing drug takes lots of money so it’s very difficult for a foreign biotech company to enter the market without help,” said Scott, “but I see policies are good here and things really start to accelerate.”